Abstract
Airway inflammation underlies pulmonary exacerbations in cystic fibrosis (CF). We tested multiple inflammatory molecules previously studied to validate specific biomarkers and pathways as potential causes of CF pulmonary exacerbations.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Paper Title
Journal
Date
